nodes	percent_of_prediction	percent_of_DWPC	metapath
Ranitidine—ABCB1—melanoma	0.26	1	CbGaD
Ranitidine—CYP1A2—Carmustine—melanoma	0.102	0.184	CbGbCtD
Ranitidine—CYP1A2—Vemurafenib—melanoma	0.0805	0.146	CbGbCtD
Ranitidine—CYP3A4—Temozolomide—melanoma	0.0769	0.139	CbGbCtD
Ranitidine—CYP2D6—Vemurafenib—melanoma	0.0663	0.12	CbGbCtD
Ranitidine—CYP1A2—Dacarbazine—melanoma	0.0617	0.112	CbGbCtD
Ranitidine—ABCB1—Dactinomycin—melanoma	0.0468	0.0847	CbGbCtD
Ranitidine—CYP3A4—Vemurafenib—melanoma	0.0422	0.0764	CbGbCtD
Ranitidine—CYP3A5—Docetaxel—melanoma	0.0371	0.0672	CbGbCtD
Ranitidine—ABCB1—Docetaxel—melanoma	0.0241	0.0438	CbGbCtD
Ranitidine—CYP3A4—Docetaxel—melanoma	0.0145	0.0262	CbGbCtD
Ranitidine—Nephrotoxicity—Carmustine—melanoma	0.00413	0.0301	CcSEcCtD
Ranitidine—Meningitis—Carmustine—melanoma	0.00338	0.0247	CcSEcCtD
Ranitidine—Nizatidine—ABCB1—melanoma	0.00303	1	CrCbGaD
Ranitidine—Nephropathy toxic—Bleomycin—melanoma	0.00262	0.0191	CcSEcCtD
Ranitidine—Vasculitis—Vemurafenib—melanoma	0.00254	0.0185	CcSEcCtD
Ranitidine—Musculoskeletal pain—Vemurafenib—melanoma	0.00251	0.0183	CcSEcCtD
Ranitidine—Nephropathy toxic—Carmustine—melanoma	0.00228	0.0167	CcSEcCtD
Ranitidine—Photosensitivity—Vemurafenib—melanoma	0.00205	0.015	CcSEcCtD
Ranitidine—Eosinophilia—Vemurafenib—melanoma	0.00154	0.0112	CcSEcCtD
Ranitidine—Foetor hepaticus—Docetaxel—melanoma	0.00149	0.0108	CcSEcCtD
Ranitidine—Wheezing—Bleomycin—melanoma	0.00146	0.0106	CcSEcCtD
Ranitidine—Photosensitivity reaction—Vemurafenib—melanoma	0.00142	0.0104	CcSEcCtD
Ranitidine—Weight decreased—Vemurafenib—melanoma	0.00141	0.0103	CcSEcCtD
Ranitidine—Aplastic anaemia—Dactinomycin—melanoma	0.00132	0.0096	CcSEcCtD
Ranitidine—Musculoskeletal pain—Temozolomide—melanoma	0.00128	0.00936	CcSEcCtD
Ranitidine—Liver disorder—Docetaxel—melanoma	0.00124	0.00902	CcSEcCtD
Ranitidine—Aplastic anaemia—Temozolomide—melanoma	0.00119	0.00868	CcSEcCtD
Ranitidine—Erythema multiforme—Vemurafenib—melanoma	0.00118	0.00859	CcSEcCtD
Ranitidine—Gynaecomastia—Carmustine—melanoma	0.00117	0.00856	CcSEcCtD
Ranitidine—Hepatic failure—Dactinomycin—melanoma	0.00113	0.00826	CcSEcCtD
Ranitidine—Alopecia—Vemurafenib—melanoma	0.0011	0.00803	CcSEcCtD
Ranitidine—Erythema—Vemurafenib—melanoma	0.00108	0.00791	CcSEcCtD
Ranitidine—Hepatic failure—Temozolomide—melanoma	0.00102	0.00747	CcSEcCtD
Ranitidine—Bronchospasm—Bleomycin—melanoma	0.000927	0.00676	CcSEcCtD
Ranitidine—Arthralgia—Vemurafenib—melanoma	0.000923	0.00673	CcSEcCtD
Ranitidine—Myalgia—Vemurafenib—melanoma	0.000923	0.00673	CcSEcCtD
Ranitidine—Pancytopenia—Bleomycin—melanoma	0.000895	0.00653	CcSEcCtD
Ranitidine—Anaphylactic shock—Vemurafenib—melanoma	0.000885	0.00645	CcSEcCtD
Ranitidine—Dysphagia—Dactinomycin—melanoma	0.000879	0.00641	CcSEcCtD
Ranitidine—Weight decreased—Bleomycin—melanoma	0.000853	0.00622	CcSEcCtD
Ranitidine—Pneumonia—Bleomycin—melanoma	0.000846	0.00617	CcSEcCtD
Ranitidine—Hepatocellular injury—Docetaxel—melanoma	0.000843	0.00615	CcSEcCtD
Ranitidine—Pancytopenia—Dactinomycin—melanoma	0.000835	0.00609	CcSEcCtD
Ranitidine—Breast disorder—Temozolomide—melanoma	0.000832	0.00607	CcSEcCtD
Ranitidine—Hypotension—Vemurafenib—melanoma	0.000827	0.00603	CcSEcCtD
Ranitidine—Dysphagia—Carmustine—melanoma	0.000823	0.006	CcSEcCtD
Ranitidine—Neutropenia—Dactinomycin—melanoma	0.000822	0.006	CcSEcCtD
Ranitidine—Alanine aminotransferase increased—Temozolomide—melanoma	0.000812	0.00592	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000806	0.00588	CcSEcCtD
Ranitidine—Dysphagia—Temozolomide—melanoma	0.000795	0.0058	CcSEcCtD
Ranitidine—Pneumonia—Dactinomycin—melanoma	0.000789	0.00575	CcSEcCtD
Ranitidine—Pancytopenia—Carmustine—melanoma	0.000782	0.0057	CcSEcCtD
Ranitidine—Neutropenia—Carmustine—melanoma	0.00077	0.00561	CcSEcCtD
Ranitidine—Constipation—Vemurafenib—melanoma	0.000757	0.00552	CcSEcCtD
Ranitidine—Pancytopenia—Temozolomide—melanoma	0.000755	0.00551	CcSEcCtD
Ranitidine—Lightheadedness—Docetaxel—melanoma	0.000754	0.0055	CcSEcCtD
Ranitidine—Neutropenia—Temozolomide—melanoma	0.000744	0.00542	CcSEcCtD
Ranitidine—Pneumonia—Carmustine—melanoma	0.000738	0.00538	CcSEcCtD
Ranitidine—Erectile dysfunction—Temozolomide—melanoma	0.000733	0.00534	CcSEcCtD
Ranitidine—Agranulocytosis—Dactinomycin—melanoma	0.000732	0.00534	CcSEcCtD
Ranitidine—Photosensitivity reaction—Temozolomide—melanoma	0.000726	0.00529	CcSEcCtD
Ranitidine—Weight decreased—Temozolomide—melanoma	0.00072	0.00525	CcSEcCtD
Ranitidine—Pneumonia—Temozolomide—melanoma	0.000713	0.0052	CcSEcCtD
Ranitidine—Hepatitis—Dactinomycin—melanoma	0.000704	0.00513	CcSEcCtD
Ranitidine—Body temperature increased—Vemurafenib—melanoma	0.0007	0.0051	CcSEcCtD
Ranitidine—Hepatic failure—Docetaxel—melanoma	0.000681	0.00497	CcSEcCtD
Ranitidine—Alopecia—Bleomycin—melanoma	0.000667	0.00486	CcSEcCtD
Ranitidine—Erythema multiforme—Dactinomycin—melanoma	0.000666	0.00485	CcSEcCtD
Ranitidine—Erythema—Bleomycin—melanoma	0.000657	0.00479	CcSEcCtD
Ranitidine—Hallucination—Carmustine—melanoma	0.000656	0.00478	CcSEcCtD
Ranitidine—Hypersensitivity—Vemurafenib—melanoma	0.000652	0.00476	CcSEcCtD
Ranitidine—Hepatitis—Temozolomide—melanoma	0.000637	0.00464	CcSEcCtD
Ranitidine—Hallucination—Temozolomide—melanoma	0.000633	0.00462	CcSEcCtD
Ranitidine—Pruritus—Vemurafenib—melanoma	0.000626	0.00457	CcSEcCtD
Ranitidine—Alopecia—Dactinomycin—melanoma	0.000622	0.00454	CcSEcCtD
Ranitidine—Erythema—Dactinomycin—melanoma	0.000613	0.00447	CcSEcCtD
Ranitidine—Ill-defined disorder—Bleomycin—melanoma	0.00061	0.00445	CcSEcCtD
Ranitidine—Anaemia—Bleomycin—melanoma	0.000607	0.00443	CcSEcCtD
Ranitidine—Diarrhoea—Vemurafenib—melanoma	0.000606	0.00442	CcSEcCtD
Ranitidine—Erythema multiforme—Temozolomide—melanoma	0.000602	0.00439	CcSEcCtD
Ranitidine—Malaise—Bleomycin—melanoma	0.000592	0.00432	CcSEcCtD
Ranitidine—Arrhythmia—Carmustine—melanoma	0.000589	0.00429	CcSEcCtD
Ranitidine—Leukopenia—Bleomycin—melanoma	0.000588	0.00429	CcSEcCtD
Ranitidine—Dizziness—Vemurafenib—melanoma	0.000585	0.00427	CcSEcCtD
Ranitidine—Alopecia—Carmustine—melanoma	0.000582	0.00425	CcSEcCtD
Ranitidine—Erythema—Carmustine—melanoma	0.000573	0.00418	CcSEcCtD
Ranitidine—Ill-defined disorder—Dactinomycin—melanoma	0.000569	0.00415	CcSEcCtD
Ranitidine—Anaemia—Dactinomycin—melanoma	0.000566	0.00413	CcSEcCtD
Ranitidine—Vomiting—Vemurafenib—melanoma	0.000563	0.0041	CcSEcCtD
Ranitidine—Alopecia—Temozolomide—melanoma	0.000563	0.0041	CcSEcCtD
Ranitidine—Myalgia—Bleomycin—melanoma	0.000559	0.00408	CcSEcCtD
Ranitidine—Chest pain—Bleomycin—melanoma	0.000559	0.00408	CcSEcCtD
Ranitidine—Abdominal pain upper—Docetaxel—melanoma	0.000559	0.00408	CcSEcCtD
Ranitidine—Rash—Vemurafenib—melanoma	0.000558	0.00407	CcSEcCtD
Ranitidine—Dermatitis—Vemurafenib—melanoma	0.000558	0.00407	CcSEcCtD
Ranitidine—Headache—Vemurafenib—melanoma	0.000554	0.00404	CcSEcCtD
Ranitidine—Erythema—Temozolomide—melanoma	0.000554	0.00404	CcSEcCtD
Ranitidine—Breast disorder—Docetaxel—melanoma	0.000553	0.00403	CcSEcCtD
Ranitidine—Discomfort—Bleomycin—melanoma	0.000553	0.00403	CcSEcCtD
Ranitidine—Malaise—Dactinomycin—melanoma	0.000553	0.00403	CcSEcCtD
Ranitidine—Leukopenia—Dactinomycin—melanoma	0.000548	0.004	CcSEcCtD
Ranitidine—Confusional state—Bleomycin—melanoma	0.000541	0.00394	CcSEcCtD
Ranitidine—Vision blurred—Carmustine—melanoma	0.00054	0.00394	CcSEcCtD
Ranitidine—Alanine aminotransferase increased—Docetaxel—melanoma	0.00054	0.00394	CcSEcCtD
Ranitidine—Anaphylactic shock—Bleomycin—melanoma	0.000536	0.00391	CcSEcCtD
Ranitidine—Anaemia—Carmustine—melanoma	0.00053	0.00387	CcSEcCtD
Ranitidine—Dysphagia—Docetaxel—melanoma	0.000529	0.00386	CcSEcCtD
Ranitidine—Agitation—Carmustine—melanoma	0.000527	0.00384	CcSEcCtD
Ranitidine—Nausea—Vemurafenib—melanoma	0.000526	0.00383	CcSEcCtD
Ranitidine—Thrombocytopenia—Bleomycin—melanoma	0.000525	0.00383	CcSEcCtD
Ranitidine—Vision blurred—Temozolomide—melanoma	0.000522	0.00381	CcSEcCtD
Ranitidine—Myalgia—Dactinomycin—melanoma	0.000522	0.0038	CcSEcCtD
Ranitidine—Bronchospasm—Docetaxel—melanoma	0.00052	0.00379	CcSEcCtD
Ranitidine—Discomfort—Dactinomycin—melanoma	0.000515	0.00376	CcSEcCtD
Ranitidine—Angina pectoris—Docetaxel—melanoma	0.000515	0.00376	CcSEcCtD
Ranitidine—Ill-defined disorder—Temozolomide—melanoma	0.000514	0.00375	CcSEcCtD
Ranitidine—Leukopenia—Carmustine—melanoma	0.000513	0.00374	CcSEcCtD
Ranitidine—Anaemia—Temozolomide—melanoma	0.000512	0.00374	CcSEcCtD
Ranitidine—Agitation—Temozolomide—melanoma	0.000509	0.00371	CcSEcCtD
Ranitidine—Angioedema—Temozolomide—melanoma	0.000506	0.00369	CcSEcCtD
Ranitidine—Pancytopenia—Docetaxel—melanoma	0.000502	0.00366	CcSEcCtD
Ranitidine—Hypotension—Bleomycin—melanoma	0.000501	0.00365	CcSEcCtD
Ranitidine—Malaise—Temozolomide—melanoma	0.0005	0.00364	CcSEcCtD
Ranitidine—Vertigo—Temozolomide—melanoma	0.000498	0.00363	CcSEcCtD
Ranitidine—Leukopenia—Temozolomide—melanoma	0.000496	0.00362	CcSEcCtD
Ranitidine—Neutropenia—Docetaxel—melanoma	0.000495	0.00361	CcSEcCtD
Ranitidine—Thrombocytopenia—Dactinomycin—melanoma	0.00049	0.00357	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Bleomycin—melanoma	0.000489	0.00356	CcSEcCtD
Ranitidine—Chest pain—Carmustine—melanoma	0.000488	0.00356	CcSEcCtD
Ranitidine—Myalgia—Carmustine—melanoma	0.000488	0.00356	CcSEcCtD
Ranitidine—Weight decreased—Docetaxel—melanoma	0.000479	0.00349	CcSEcCtD
Ranitidine—Dyspnoea—Bleomycin—melanoma	0.000478	0.00349	CcSEcCtD
Ranitidine—Pneumonia—Docetaxel—melanoma	0.000474	0.00346	CcSEcCtD
Ranitidine—Confusional state—Carmustine—melanoma	0.000472	0.00344	CcSEcCtD
Ranitidine—Arthralgia—Temozolomide—melanoma	0.000472	0.00344	CcSEcCtD
Ranitidine—Myalgia—Temozolomide—melanoma	0.000472	0.00344	CcSEcCtD
Ranitidine—Discomfort—Temozolomide—melanoma	0.000466	0.0034	CcSEcCtD
Ranitidine—Jaundice—Docetaxel—melanoma	0.00046	0.00335	CcSEcCtD
Ranitidine—Pain—Bleomycin—melanoma	0.000459	0.00334	CcSEcCtD
Ranitidine—Thrombocytopenia—Carmustine—melanoma	0.000458	0.00334	CcSEcCtD
Ranitidine—Tachycardia—Carmustine—melanoma	0.000457	0.00333	CcSEcCtD
Ranitidine—Confusional state—Temozolomide—melanoma	0.000456	0.00333	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000456	0.00332	CcSEcCtD
Ranitidine—Anaphylactic shock—Temozolomide—melanoma	0.000452	0.0033	CcSEcCtD
Ranitidine—Thrombocytopenia—Temozolomide—melanoma	0.000443	0.00323	CcSEcCtD
Ranitidine—Feeling abnormal—Bleomycin—melanoma	0.000442	0.00322	CcSEcCtD
Ranitidine—Agranulocytosis—Docetaxel—melanoma	0.00044	0.00321	CcSEcCtD
Ranitidine—Hypotension—Carmustine—melanoma	0.000437	0.00319	CcSEcCtD
Ranitidine—Hyperhidrosis—Temozolomide—melanoma	0.000437	0.00319	CcSEcCtD
Ranitidine—Pain—Dactinomycin—melanoma	0.000428	0.00312	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Carmustine—melanoma	0.000426	0.00311	CcSEcCtD
Ranitidine—Urticaria—Bleomycin—melanoma	0.000426	0.00311	CcSEcCtD
Ranitidine—Body temperature increased—Bleomycin—melanoma	0.000424	0.00309	CcSEcCtD
Ranitidine—Hepatitis—Docetaxel—melanoma	0.000423	0.00309	CcSEcCtD
Ranitidine—Insomnia—Carmustine—melanoma	0.000423	0.00309	CcSEcCtD
Ranitidine—Dyspnoea—Carmustine—melanoma	0.000417	0.00304	CcSEcCtD
Ranitidine—Somnolence—Carmustine—melanoma	0.000416	0.00303	CcSEcCtD
Ranitidine—Feeling abnormal—Dactinomycin—melanoma	0.000412	0.00301	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Temozolomide—melanoma	0.000412	0.00301	CcSEcCtD
Ranitidine—Insomnia—Temozolomide—melanoma	0.000409	0.00298	CcSEcCtD
Ranitidine—Dyspnoea—Temozolomide—melanoma	0.000403	0.00294	CcSEcCtD
Ranitidine—Somnolence—Temozolomide—melanoma	0.000402	0.00293	CcSEcCtD
Ranitidine—Erythema multiforme—Docetaxel—melanoma	0.0004	0.00292	CcSEcCtD
Ranitidine—Pain—Carmustine—melanoma	0.0004	0.00292	CcSEcCtD
Ranitidine—Constipation—Carmustine—melanoma	0.0004	0.00292	CcSEcCtD
Ranitidine—Abdominal pain—Dactinomycin—melanoma	0.000395	0.00288	CcSEcCtD
Ranitidine—Body temperature increased—Dactinomycin—melanoma	0.000395	0.00288	CcSEcCtD
Ranitidine—Hypersensitivity—Bleomycin—melanoma	0.000395	0.00288	CcSEcCtD
Ranitidine—Pain—Temozolomide—melanoma	0.000387	0.00282	CcSEcCtD
Ranitidine—Constipation—Temozolomide—melanoma	0.000387	0.00282	CcSEcCtD
Ranitidine—Feeling abnormal—Carmustine—melanoma	0.000386	0.00281	CcSEcCtD
Ranitidine—Pruritus—Bleomycin—melanoma	0.000379	0.00277	CcSEcCtD
Ranitidine—Arrhythmia—Docetaxel—melanoma	0.000378	0.00276	CcSEcCtD
Ranitidine—Alopecia—Docetaxel—melanoma	0.000374	0.00273	CcSEcCtD
Ranitidine—Feeling abnormal—Temozolomide—melanoma	0.000373	0.00272	CcSEcCtD
Ranitidine—Abdominal pain—Carmustine—melanoma	0.00037	0.0027	CcSEcCtD
Ranitidine—Body temperature increased—Carmustine—melanoma	0.00037	0.0027	CcSEcCtD
Ranitidine—Erythema—Docetaxel—melanoma	0.000369	0.00269	CcSEcCtD
Ranitidine—Hypersensitivity—Dactinomycin—melanoma	0.000368	0.00269	CcSEcCtD
Ranitidine—Urticaria—Temozolomide—melanoma	0.000359	0.00262	CcSEcCtD
Ranitidine—Body temperature increased—Temozolomide—melanoma	0.000358	0.00261	CcSEcCtD
Ranitidine—Abdominal pain—Temozolomide—melanoma	0.000358	0.00261	CcSEcCtD
Ranitidine—Hypersensitivity—Carmustine—melanoma	0.000345	0.00251	CcSEcCtD
Ranitidine—Diarrhoea—Dactinomycin—melanoma	0.000342	0.0025	CcSEcCtD
Ranitidine—Vomiting—Bleomycin—melanoma	0.000341	0.00249	CcSEcCtD
Ranitidine—Anaemia—Docetaxel—melanoma	0.000341	0.00248	CcSEcCtD
Ranitidine—Rash—Bleomycin—melanoma	0.000338	0.00247	CcSEcCtD
Ranitidine—Dermatitis—Bleomycin—melanoma	0.000338	0.00246	CcSEcCtD
Ranitidine—Hypersensitivity—Temozolomide—melanoma	0.000333	0.00243	CcSEcCtD
Ranitidine—Leukopenia—Docetaxel—melanoma	0.00033	0.00241	CcSEcCtD
Ranitidine—Diarrhoea—Carmustine—melanoma	0.00032	0.00234	CcSEcCtD
Ranitidine—Pruritus—Temozolomide—melanoma	0.00032	0.00233	CcSEcCtD
Ranitidine—Nausea—Bleomycin—melanoma	0.000319	0.00232	CcSEcCtD
Ranitidine—Vomiting—Dactinomycin—melanoma	0.000318	0.00232	CcSEcCtD
Ranitidine—Rash—Dactinomycin—melanoma	0.000315	0.0023	CcSEcCtD
Ranitidine—Myalgia—Docetaxel—melanoma	0.000314	0.00229	CcSEcCtD
Ranitidine—Arthralgia—Docetaxel—melanoma	0.000314	0.00229	CcSEcCtD
Ranitidine—Chest pain—Docetaxel—melanoma	0.000314	0.00229	CcSEcCtD
Ranitidine—Dizziness—Carmustine—melanoma	0.00031	0.00226	CcSEcCtD
Ranitidine—Diarrhoea—Temozolomide—melanoma	0.000309	0.00226	CcSEcCtD
Ranitidine—Confusional state—Docetaxel—melanoma	0.000303	0.00221	CcSEcCtD
Ranitidine—Anaphylactic shock—Docetaxel—melanoma	0.000301	0.00219	CcSEcCtD
Ranitidine—Dizziness—Temozolomide—melanoma	0.000299	0.00218	CcSEcCtD
Ranitidine—Vomiting—Carmustine—melanoma	0.000298	0.00217	CcSEcCtD
Ranitidine—Nausea—Dactinomycin—melanoma	0.000297	0.00217	CcSEcCtD
Ranitidine—Rash—Carmustine—melanoma	0.000295	0.00215	CcSEcCtD
Ranitidine—Dermatitis—Carmustine—melanoma	0.000295	0.00215	CcSEcCtD
Ranitidine—Thrombocytopenia—Docetaxel—melanoma	0.000295	0.00215	CcSEcCtD
Ranitidine—Tachycardia—Docetaxel—melanoma	0.000294	0.00214	CcSEcCtD
Ranitidine—Headache—Carmustine—melanoma	0.000293	0.00214	CcSEcCtD
Ranitidine—Vomiting—Temozolomide—melanoma	0.000288	0.0021	CcSEcCtD
Ranitidine—Rash—Temozolomide—melanoma	0.000285	0.00208	CcSEcCtD
Ranitidine—Dermatitis—Temozolomide—melanoma	0.000285	0.00208	CcSEcCtD
Ranitidine—Headache—Temozolomide—melanoma	0.000283	0.00207	CcSEcCtD
Ranitidine—Hypotension—Docetaxel—melanoma	0.000281	0.00205	CcSEcCtD
Ranitidine—Nausea—Carmustine—melanoma	0.000278	0.00203	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Docetaxel—melanoma	0.000274	0.002	CcSEcCtD
Ranitidine—Insomnia—Docetaxel—melanoma	0.000272	0.00198	CcSEcCtD
Ranitidine—Nausea—Temozolomide—melanoma	0.000269	0.00196	CcSEcCtD
Ranitidine—Dyspnoea—Docetaxel—melanoma	0.000268	0.00196	CcSEcCtD
Ranitidine—Somnolence—Docetaxel—melanoma	0.000267	0.00195	CcSEcCtD
Ranitidine—Pain—Docetaxel—melanoma	0.000257	0.00188	CcSEcCtD
Ranitidine—Constipation—Docetaxel—melanoma	0.000257	0.00188	CcSEcCtD
Ranitidine—Feeling abnormal—Docetaxel—melanoma	0.000248	0.00181	CcSEcCtD
Ranitidine—Abdominal pain—Docetaxel—melanoma	0.000238	0.00173	CcSEcCtD
Ranitidine—Body temperature increased—Docetaxel—melanoma	0.000238	0.00173	CcSEcCtD
Ranitidine—Hypersensitivity—Docetaxel—melanoma	0.000222	0.00162	CcSEcCtD
Ranitidine—Pruritus—Docetaxel—melanoma	0.000213	0.00155	CcSEcCtD
Ranitidine—Diarrhoea—Docetaxel—melanoma	0.000206	0.0015	CcSEcCtD
Ranitidine—Dizziness—Docetaxel—melanoma	0.000199	0.00145	CcSEcCtD
Ranitidine—Vomiting—Docetaxel—melanoma	0.000191	0.00139	CcSEcCtD
Ranitidine—Rash—Docetaxel—melanoma	0.00019	0.00138	CcSEcCtD
Ranitidine—Dermatitis—Docetaxel—melanoma	0.000189	0.00138	CcSEcCtD
Ranitidine—Headache—Docetaxel—melanoma	0.000188	0.00137	CcSEcCtD
Ranitidine—Nausea—Docetaxel—melanoma	0.000179	0.0013	CcSEcCtD
Ranitidine—CYP1A2—Metabolism—SLC6A11—melanoma	1.5e-05	0.000315	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PIP4K2A—melanoma	1.5e-05	0.000315	CbGpPWpGaD
Ranitidine—SLC22A1—Transmembrane transport of small molecules—ALB—melanoma	1.49e-05	0.000313	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—FASN—melanoma	1.49e-05	0.000313	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—VCAN—melanoma	1.49e-05	0.000312	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—CUBN—melanoma	1.48e-05	0.00031	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—GPAM—melanoma	1.47e-05	0.000308	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—SLC5A5—melanoma	1.47e-05	0.000308	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—MTAP—melanoma	1.46e-05	0.000306	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—HIF1A—melanoma	1.45e-05	0.000305	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	1.44e-05	0.000302	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—SDHD—melanoma	1.43e-05	0.0003	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—CSPG4—melanoma	1.43e-05	0.0003	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—BSG—melanoma	1.43e-05	0.0003	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	1.43e-05	0.000299	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—GNAQ—melanoma	1.42e-05	0.000297	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—CD44—melanoma	1.42e-05	0.000297	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	1.4e-05	0.000293	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—KDR—melanoma	1.39e-05	0.000292	CbGpPWpGaD
Ranitidine—SLC22A1—Neuronal System—HRAS—melanoma	1.38e-05	0.00029	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—GPAM—melanoma	1.38e-05	0.00029	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	1.37e-05	0.000287	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	1.37e-05	0.000287	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—CYP1B1—melanoma	1.36e-05	0.000285	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—FN1—melanoma	1.34e-05	0.000281	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—NOTCH1—melanoma	1.31e-05	0.000275	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	1.3e-05	0.000273	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—LUM—melanoma	1.3e-05	0.000273	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PHGDH—melanoma	1.3e-05	0.000273	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	1.29e-05	0.000271	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CD80—melanoma	1.28e-05	0.000269	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—APC—melanoma	1.28e-05	0.000269	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—PIK3CG—melanoma	1.28e-05	0.000269	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—KIT—melanoma	1.28e-05	0.000269	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—NRAS—melanoma	1.28e-05	0.000269	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PLA2G6—melanoma	1.28e-05	0.000268	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—HPSE—melanoma	1.28e-05	0.000268	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—EGF—melanoma	1.27e-05	0.000266	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—CYP17A1—melanoma	1.25e-05	0.000263	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CUBN—melanoma	1.25e-05	0.000263	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PLA2G6—melanoma	1.25e-05	0.000262	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PLCB4—melanoma	1.23e-05	0.000259	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—MAPK3—melanoma	1.23e-05	0.000257	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CSPG4—melanoma	1.21e-05	0.000254	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—SDHD—melanoma	1.21e-05	0.000254	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—BSG—melanoma	1.21e-05	0.000254	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—BRAF—melanoma	1.2e-05	0.000253	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	1.19e-05	0.000249	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—GNA11—melanoma	1.18e-05	0.000248	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PLA2G6—melanoma	1.18e-05	0.000247	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—IGF1—melanoma	1.17e-05	0.000246	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—GPAM—melanoma	1.17e-05	0.000246	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—MAPK1—melanoma	1.17e-05	0.000245	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—EGFR—melanoma	1.17e-05	0.000245	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—SLC6A11—melanoma	1.16e-05	0.000243	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PIP4K2A—melanoma	1.16e-05	0.000243	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—FASN—melanoma	1.16e-05	0.000243	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—VCAN—melanoma	1.15e-05	0.000241	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	1.15e-05	0.000241	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—SLC5A5—melanoma	1.14e-05	0.000239	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—MAP2K1—melanoma	1.13e-05	0.000238	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—MTAP—melanoma	1.13e-05	0.000236	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—PIK3CD—melanoma	1.13e-05	0.000236	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—VCAN—melanoma	1.12e-05	0.000235	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—ABCB1—melanoma	1.12e-05	0.000235	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—PIK3CA—melanoma	1.12e-05	0.000234	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—KRAS—melanoma	1.1e-05	0.000231	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—CD44—melanoma	1.1e-05	0.000231	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—GNAQ—melanoma	1.1e-05	0.000231	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.09e-05	0.000228	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—FGF2—melanoma	1.08e-05	0.000226	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—VCAN—melanoma	1.06e-05	0.000222	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—CYP1B1—melanoma	1.06e-05	0.000221	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.05e-05	0.00022	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PRKCA—melanoma	1.03e-05	0.000216	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—ERCC2—melanoma	1.02e-05	0.000214	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—PIK3CA—melanoma	1.01e-05	0.000212	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—MDM2—melanoma	1.01e-05	0.000212	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PHGDH—melanoma	1.01e-05	0.000211	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—LUM—melanoma	1.01e-05	0.000211	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PLA2G6—melanoma	9.97e-06	0.000209	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—ERBB2—melanoma	9.95e-06	0.000209	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—HPSE—melanoma	9.86e-06	0.000207	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—PIK3CB—melanoma	9.82e-06	0.000206	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	9.7e-06	0.000203	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—CYP17A1—melanoma	9.7e-06	0.000203	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CUBN—melanoma	9.67e-06	0.000203	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	9.56e-06	0.000201	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—CYP17A1—melanoma	9.46e-06	0.000198	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	9.44e-06	0.000198	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CXCL8—melanoma	9.44e-06	0.000198	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—HRAS—melanoma	9.38e-06	0.000197	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—SDHD—melanoma	9.34e-06	0.000196	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CSPG4—melanoma	9.34e-06	0.000196	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—BSG—melanoma	9.34e-06	0.000196	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CDKN1B—melanoma	9.22e-06	0.000193	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—GNA11—melanoma	9.16e-06	0.000192	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—AKT1—melanoma	9.12e-06	0.000191	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GPAM—melanoma	9.05e-06	0.00019	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CASP3—melanoma	9.03e-06	0.000189	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—IL2—melanoma	9.02e-06	0.000189	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—IL6—melanoma	8.97e-06	0.000188	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—FASN—melanoma	8.96e-06	0.000188	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—VCAN—melanoma	8.96e-06	0.000188	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—GNA11—melanoma	8.94e-06	0.000187	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—CYP17A1—melanoma	8.92e-06	0.000187	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—SLC5A5—melanoma	8.82e-06	0.000185	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CCND1—melanoma	8.79e-06	0.000184	CbGpPWpGaD
Ranitidine—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	8.76e-06	0.000184	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—FASN—melanoma	8.75e-06	0.000183	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CTNNB1—melanoma	8.71e-06	0.000183	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—ABCB1—melanoma	8.69e-06	0.000182	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—SLC5A5—melanoma	8.6e-06	0.00018	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—MMP9—melanoma	8.54e-06	0.000179	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—GNAQ—melanoma	8.51e-06	0.000179	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—CD44—melanoma	8.51e-06	0.000179	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CDKN1A—melanoma	8.5e-06	0.000178	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—PTEN—melanoma	8.49e-06	0.000178	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	8.48e-06	0.000178	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—NFKB1—melanoma	8.44e-06	0.000177	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—GNA11—melanoma	8.42e-06	0.000177	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	8.34e-06	0.000175	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—GNAQ—melanoma	8.31e-06	0.000174	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—CD44—melanoma	8.31e-06	0.000174	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—AKT1—melanoma	8.28e-06	0.000174	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	8.26e-06	0.000173	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—FASN—melanoma	8.24e-06	0.000173	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	8.18e-06	0.000172	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—CYP1B1—melanoma	8.16e-06	0.000171	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—SLC5A5—melanoma	8.11e-06	0.00017	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PIK3CG—melanoma	8.07e-06	0.000169	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PRKCA—melanoma	8e-06	0.000168	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—CYP1B1—melanoma	7.97e-06	0.000167	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—ERCC2—melanoma	7.94e-06	0.000166	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—GNAQ—melanoma	7.83e-06	0.000164	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—CD44—melanoma	7.83e-06	0.000164	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PPARG—melanoma	7.79e-06	0.000163	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PLA2G6—melanoma	7.69e-06	0.000161	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—VEGFA—melanoma	7.66e-06	0.000161	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—STAT3—melanoma	7.59e-06	0.000159	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—NRAS—melanoma	7.57e-06	0.000159	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CYP17A1—melanoma	7.56e-06	0.000158	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—CYP1B1—melanoma	7.51e-06	0.000157	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	7.45e-06	0.000156	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	7.36e-06	0.000154	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—MAPK3—melanoma	7.25e-06	0.000152	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	7.2e-06	0.000151	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—GNA11—melanoma	7.14e-06	0.00015	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PIK3CD—melanoma	7.09e-06	0.000149	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—MYC—melanoma	7.05e-06	0.000148	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—ALB—melanoma	7e-06	0.000147	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—FASN—melanoma	6.98e-06	0.000146	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—VCAN—melanoma	6.91e-06	0.000145	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—MAPK1—melanoma	6.9e-06	0.000145	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—EGFR—melanoma	6.9e-06	0.000145	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—SLC5A5—melanoma	6.87e-06	0.000144	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—ABCB1—melanoma	6.72e-06	0.000141	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—GNAQ—melanoma	6.63e-06	0.000139	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CD44—melanoma	6.63e-06	0.000139	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—KRAS—melanoma	6.52e-06	0.000137	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	6.5e-06	0.000136	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	6.44e-06	0.000135	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CYP1B1—melanoma	6.36e-06	0.000133	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PIK3CG—melanoma	6.27e-06	0.000131	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PRKCA—melanoma	6.19e-06	0.00013	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PIK3CB—melanoma	6.18e-06	0.00013	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—ABCB1—melanoma	6.18e-06	0.00013	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—ERCC2—melanoma	6.14e-06	0.000129	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PTGS2—melanoma	6.13e-06	0.000128	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PPARG—melanoma	6.05e-06	0.000127	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PRKCA—melanoma	6.04e-06	0.000127	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—ERCC2—melanoma	5.99e-06	0.000126	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—PIK3CA—melanoma	5.99e-06	0.000126	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CYP17A1—melanoma	5.83e-06	0.000122	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—TP53—melanoma	5.79e-06	0.000121	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PRKCA—melanoma	5.69e-06	0.000119	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—ERCC2—melanoma	5.64e-06	0.000118	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	5.61e-06	0.000118	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—HRAS—melanoma	5.54e-06	0.000116	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PIK3CD—melanoma	5.51e-06	0.000116	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GNA11—melanoma	5.51e-06	0.000115	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—ALB—melanoma	5.44e-06	0.000114	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—FASN—melanoma	5.39e-06	0.000113	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PTEN—melanoma	5.34e-06	0.000112	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—IL6—melanoma	5.3e-06	0.000111	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—SLC5A5—melanoma	5.3e-06	0.000111	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—ABCB1—melanoma	5.24e-06	0.00011	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GNAQ—melanoma	5.12e-06	0.000107	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CD44—melanoma	5.12e-06	0.000107	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.08e-06	0.000107	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CYP1B1—melanoma	4.91e-06	0.000103	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—AKT1—melanoma	4.89e-06	0.000103	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PIK3CG—melanoma	4.85e-06	0.000102	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PRKCA—melanoma	4.82e-06	0.000101	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PIK3CB—melanoma	4.8e-06	0.000101	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—ERCC2—melanoma	4.78e-06	0.0001	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PTGS2—melanoma	4.76e-06	9.98e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PIK3CG—melanoma	4.73e-06	9.92e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PPARG—melanoma	4.68e-06	9.8e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PPARG—melanoma	4.56e-06	9.57e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PIK3CG—melanoma	4.46e-06	9.34e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PPARG—melanoma	4.3e-06	9.02e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PIK3CD—melanoma	4.26e-06	8.93e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—ALB—melanoma	4.2e-06	8.82e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PIK3CD—melanoma	4.16e-06	8.72e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PTEN—melanoma	4.15e-06	8.7e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—ALB—melanoma	4.1e-06	8.6e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—ABCB1—melanoma	4.04e-06	8.47e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.96e-06	8.3e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PIK3CD—melanoma	3.92e-06	8.21e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—ALB—melanoma	3.87e-06	8.11e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PIK3CG—melanoma	3.78e-06	7.92e-05	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PIK3CA—melanoma	3.77e-06	7.9e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PRKCA—melanoma	3.72e-06	7.8e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PIK3CB—melanoma	3.71e-06	7.78e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—ERCC2—melanoma	3.69e-06	7.74e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PTGS2—melanoma	3.68e-06	7.71e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PPARG—melanoma	3.64e-06	7.64e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PIK3CB—melanoma	3.62e-06	7.6e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PTGS2—melanoma	3.59e-06	7.53e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PIK3CB—melanoma	3.41e-06	7.16e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PTGS2—melanoma	3.38e-06	7.09e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PIK3CD—melanoma	3.32e-06	6.96e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—ALB—melanoma	3.28e-06	6.87e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PTEN—melanoma	3.21e-06	6.73e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PTEN—melanoma	3.13e-06	6.57e-05	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—AKT1—melanoma	3.08e-06	6.46e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PTEN—melanoma	2.95e-06	6.19e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PIK3CA—melanoma	2.93e-06	6.14e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PIK3CG—melanoma	2.91e-06	6.11e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PIK3CB—melanoma	2.89e-06	6.07e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PTGS2—melanoma	2.87e-06	6.01e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PPARG—melanoma	2.81e-06	5.9e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PIK3CD—melanoma	2.56e-06	5.37e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—ALB—melanoma	2.53e-06	5.3e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PTEN—melanoma	2.5e-06	5.24e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—AKT1—melanoma	2.39e-06	5.01e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PIK3CA—melanoma	2.26e-06	4.75e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PIK3CB—melanoma	2.23e-06	4.68e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PTGS2—melanoma	2.21e-06	4.64e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PIK3CA—melanoma	2.21e-06	4.63e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PIK3CA—melanoma	2.08e-06	4.36e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PTEN—melanoma	1.93e-06	4.04e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—AKT1—melanoma	1.85e-06	3.88e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—AKT1—melanoma	1.8e-06	3.78e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PIK3CA—melanoma	1.76e-06	3.7e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—AKT1—melanoma	1.7e-06	3.57e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—AKT1—melanoma	1.44e-06	3.02e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PIK3CA—melanoma	1.36e-06	2.85e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—AKT1—melanoma	1.11e-06	2.33e-05	CbGpPWpGaD
